GSK Biologicals' GSK2340274A (two different formulations)
114495
Phase 2 mab completed
Quick answer
GSK Biologicals' GSK2340274A (two different formulations) for Influenza is a Phase 2 program (mab) at GlaxoSmithKline with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GlaxoSmithKline
- Indication
- Influenza
- Phase
- Phase 2
- Modality
- mab
- Status
- completed